Clinical Trial Update: Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing sisomicin cream to nadifloxacin cream for primary pyodermas was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyoderma

Drugs mentioned

• Nadifloxacin cream (Nadifloxacin)
• Sisomicin Cream (sisomicin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pyoderma | Phase 4 | Status: WITHDRAWN